Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Buying Homex Development Corp. (ADR) (HXM)

Page 1 of 2

What’s a smart Homex Development Corp. (ADR) (NYSE:HXM) investor to do?

In the 21st century investor’s toolkit, there are dozens of metrics shareholders can use to monitor Mr. Market. A couple of the most underrated are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best fund managers can outclass their index-focused peers by a solid margin (see just how much).

Just as key, optimistic insider trading sentiment is another way to analyze the stock market universe. There are plenty of reasons for an executive to cut shares of his or her company, but only one, very obvious reason why they would initiate a purchase. Several academic studies have demonstrated the valuable potential of this tactic if investors understand where to look (learn more here).


Keeping this in mind, let’s examine the recent info for Homex Development Corp. (ADR) (NYSE:HXM).

What have hedge funds been doing with Homex Development Corp. (ADR) (NYSE:HXM)?

At Q2’s end, a total of 6 of the hedge funds we track held long positions in this stock, a change of 20% from the first quarter. With hedge funds’ sentiment swirling, there exists a few key hedge fund managers who were upping their holdings considerably.

According to our 13F database, Luxor Capital Group, managed by Christian Leone, holds the most valuable position in Homex Development Corp. (ADR) (NYSE:HXM). Luxor Capital Group has a $2 million position in the stock, comprising 0.1% of its 13F portfolio. The second largest stake is held by Jim Simons of Renaissance Technologies, with a $1.2 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Other hedge funds with similar optimism include Ken Griffin’s Citadel Investment Group, Martin Whitman’s Third Avenue Management and Matthew Hulsizer’s PEAK6 Capital Management.

As aggregate interest spiked, particular hedge funds have jumped into Homex Development Corp. (ADR) (NYSE:HXM) headfirst. Luxor Capital Group, managed by Christian Leone, initiated the biggest position in Homex Development Corp. (ADR) (NYSE:HXM). Luxor Capital Group had 2 million invested in the company at the end of the quarter. Jim Simons’s Renaissance Technologies also made a $1.2 million investment in the stock during the quarter. The other funds with new positions in the stock are Ken Griffin’s Citadel Investment Group, Martin Whitman’s Third Avenue Management, and Matthew Hulsizer’s PEAK6 Capital Management.

What do corporate executives and insiders think about Homex Development Corp. (ADR) (NYSE:HXM)?

Insider buying made by high-level executives is particularly usable when the company in focus has seen transactions within the past half-year. Over the last six-month time frame, Homex Development Corp. (ADR) (NYSE:HXM) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also examine the relationship between both of these indicators in other stocks similar to Homex Development Corp. (ADR) (NYSE:HXM). These stocks are Agree Realty Corporation (NYSE:ADC), Tejon Ranch Company (NYSE:TRC), E-House (China) Holdings Limited (ADR) (NYSE:EJ), Campus Crest Communities Inc (NYSE:CCG), and Alto Palermo S.A. (ADR) (NASDAQ:APSA). This group of stocks are the members of the property management industry and their market caps are closest to HXM’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!